Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia

被引:17
作者
Brahimi, M [1 ]
Dahan, M [1 ]
Dabiré, H [1 ]
Levy, BI [1 ]
机构
[1] Hop Lariboisiere, Dept Physiol & Clin Invest, F-75475 Paris 10, France
关键词
cardiac hypertrophy; end-stage renal disease; hypertension; peripheral vascular disease;
D O I
10.1097/00004872-200018110-00016
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To evaluate the degree of cardiac hypertrophy in patients with end-stage renal disease (ESRD) in comparison with that in patients with uncomplicated hypertension and in patients with peripheral vascular disease (PVD), at the same values of mean blood pressure. Design Thirty-six ambulatory hypertensive patients were investigated, 11 with ESRD, 14 with PVD and 11 with uncomplicated hypertension, matched for age, sex, mean arterial pressure and antihypertensive drug treatment. Methods Cardiac mass was determined using M-mode echocardiography together with measurement of systemic blood pressure and the ratio between ankle and arm systolic blood pressures. Results At the same mean arterial pressure, patients with ESRD developed a greater degree of cardiac hypertrophy in comparison with those with uncomplicated hypertension (P<0.01) and patients with PVD (P<0.05). The pulse pressure was significantly greater in patients with ESRD than in those with uncomplicated hypertension (P<0.01) and those with PVD (P<0.05). Multiple regression analysis showed that only pulse pressure was positively correlated to cardiac mass (r=0.62, P<0.001), suggesting a predominant impact of pulse pressure on left ventricular mass in patients with ESRD. Conclusions In patients with chronic uraemia, left ventricular hypertrophy seems to be strongly and independently associated with pulse pressure. J Hypertens 18:1645-1650 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1645 / 1650
页数:6
相关论文
共 20 条
[1]   CHANGES OF VASCULAR ARCHITECTURE-INDEPENDENT OF BLOOD-PRESSURE IN EXPERIMENTAL UREMIA [J].
AMANN, K ;
NEUSUSS, R ;
RITZ, E ;
IRZYNIEC, T ;
WIEST, G ;
MALL, G .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (04) :409-417
[2]   Factor determining cardiac hypertrophy in hypertensive patients with or without peripheral vascular disease [J].
Brahimi, M ;
Levy, BI ;
Safar, ME ;
Dabiré, H .
CLINICAL SCIENCE, 1998, 95 (03) :261-267
[3]   ACCELERATED ATHEROSCLEROSIS IN CHRONIC-DIALYSIS PATIENTS - ANOTHER LOOK [J].
BURKE, JF ;
FRANCOS, GC ;
MOORE, LL ;
CHO, SY ;
LASKER, N .
NEPHRON, 1978, 21 (04) :181-185
[4]   NONINVASIVELY DIAGNOSED PERIPHERAL ARTERIAL-DISEASE AS A PREDICTOR OF MORTALITY - RESULTS FROM A PROSPECTIVE-STUDY [J].
CRIQUI, MH ;
COUGHLIN, SS ;
FRONEK, A .
CIRCULATION, 1985, 72 (04) :768-773
[5]  
Dzau V J, 1993, Curr Opin Nephrol Hypertens, V2, P27, DOI 10.1097/00041552-199301000-00004
[6]   CARDIAC-HYPERTROPHY - USEFUL ADAPTATION OR PATHOLOGIC PROCESS [J].
GROSSMAN, W .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :576-584
[7]   Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention [J].
Levin, A ;
Singer, J ;
Thompson, CR ;
Ross, H ;
Lewis, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :347-354
[8]   VASCULAR CHANGES IN HEMODIALYSIS-PATIENTS IN RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN [J].
LONDON, GM ;
ZINS, B ;
PANNIER, B ;
NARET, C ;
BERTHELOT, JM ;
JACQUOT, C ;
SAFAR, M ;
DRUEKE, TB .
KIDNEY INTERNATIONAL, 1989, 36 (05) :878-882
[9]   AORTIC AND LARGE ARTERY COMPLIANCE IN END-STAGE RENAL-FAILURE [J].
LONDON, GM ;
MARCHAIS, SJ ;
SAFAR, ME ;
GENEST, AF ;
GUERIN, AP ;
METIVIER, F ;
CHEDID, K ;
LONDON, AM .
KIDNEY INTERNATIONAL, 1990, 37 (01) :137-142
[10]   Cardiac and arterial interactions in end-stage renal disease [J].
London, GM ;
Guerin, AP ;
Marchais, SJ ;
Pannier, B ;
Safar, ME ;
Day, M ;
Metivier, F .
KIDNEY INTERNATIONAL, 1996, 50 (02) :600-608